Association of gut microbiome and treatment outcomes with enzalutamide and darolutamide in castrate resistant prostate cancer

Project: Research project

Project Details

Description

Association of gut microbiome and treatment outcomes with enzalutamide and darolutamide in castrate resistant prostate cancer
StatusFinished
Effective start/end date9/1/212/28/23

Funding

  • BRIGHAM AND WOMEN'S HOSPITAL
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.